| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 05/05/1999 | CN1216063A IL-6 mutein |
| 05/05/1999 | CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors |
| 05/05/1999 | CN1215991A Enteric-coated pharmaceutical compositions of mycophenolate |
| 05/05/1999 | CN1215990A IL-8 receptor antagonists |
| 05/04/1999 | US5900434 Method for inhibiting the production of interleukin-1 or tumor necrosis factor-α by administering acanthoic acid |
| 05/04/1999 | US5900421 Methods and compositions for treating allergic asthma and dermatitis using descarboethoxyloratadine |
| 05/04/1999 | US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists |
| 05/04/1999 | US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles |
| 05/04/1999 | US5900238 Vaccine delivery system |
| 05/04/1999 | US5900237 Catalytic antibodies which hydrolyze primary amides and methods for eliciting such antibodies |
| 05/04/1999 | US5900235 Polypeptides |
| 05/04/1999 | CA2184604C Bicyclic carbamates |
| 05/04/1999 | CA2037333C Dna encoding a major mite allergen and the use thereof |
| 05/04/1999 | CA1340527C Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities |
| 04/30/1999 | CA2219867A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 04/29/1999 | WO1999020794A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immnunoreceptors |
| 04/29/1999 | WO1999020759A1 Chemokines with amino-terminal modifications |
| 04/29/1999 | WO1999020755A2 Novel cytokine receptors |
| 04/29/1999 | WO1999020653A1 Low-toxicity human interferon-alpha analog |
| 04/29/1999 | WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | WO1999020643A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | WO1999020625A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | WO1999020624A1 Bicyclic kinase inhibitors |
| 04/29/1999 | WO1999020601A1 α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
| 04/29/1999 | WO1999020306A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/29/1999 | WO1999020302A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | WO1999020296A1 Oral cyclosporin formulations |
| 04/29/1999 | WO1999020260A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 04/29/1999 | WO1998058669A3 Cd154 blockade therapy for pancreatic islet tissue transplantation |
| 04/29/1999 | CA2308773A1 Estra-1,3,5(10)-triene-7alpha-thioethers |
| 04/29/1999 | CA2307012A1 Xenogeneic cholesteryl ester transfer protein (cetp) for modulation of cetp activity |
| 04/29/1999 | CA2306995A1 Compositions and methods for systemic delivery of oral vaccines and therapeutic agents |
| 04/29/1999 | CA2306980A1 Novel polymorphic forms of cipamfylline |
| 04/29/1999 | CA2306870A1 Bicyclic kinase inhibitors |
| 04/29/1999 | CA2306731A1 Using polyamide nucleic acid oligomers to engender a biological response |
| 04/29/1999 | CA2306445A1 Documentation means for repertoires of nkr immunoreceptors and/or activatory or non-inhibitory immunoreceptor counterparts of nkr immunoreceptors |
| 04/29/1999 | CA2305798A1 .alpha.-aryl-n-alkylnitrones and pharmaceutical compositions containing the same |
| 04/29/1999 | CA2275773A1 Oral cyclosporin formulations |
| 04/28/1999 | EP0911633A1 A method of identifying agonists and antagonists for tumor necrosis related receptors TR1, TR3 and TR5 |
| 04/28/1999 | EP0911406A2 Histidine kinase from Staphylococcus aureus |
| 04/28/1999 | EP0911399A2 A kringle-related clone, HTHBZ47 |
| 04/28/1999 | EP0911333A1 Pyrazolo[4,3-d]pyrimidine derivatives and pharmaceutical compositions containing them |
| 04/28/1999 | EP0911037A1 Room temperature storable immunoglobulin preparation for intravenous injection |
| 04/28/1999 | EP0911036A2 Dual carrier immunogenic construct |
| 04/28/1999 | EP0910655A1 Vaccines for treatment of lymphoma and leukemia |
| 04/28/1999 | EP0910646A1 Brain glycogen phosphorylase cancer antigen |
| 04/28/1999 | EP0910638A2 Polynucleotide encoding secreted proteins |
| 04/28/1999 | EP0910635A1 Hematopoietic cytokine receptor |
| 04/28/1999 | EP0910579A1 Compounds with growth hormone releasing properties |
| 04/28/1999 | EP0910410A1 Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds |
| 04/28/1999 | EP0910407A1 Method and composition for reconforming multi-epitopic antigens to initiate an immune response |
| 04/28/1999 | EP0910406A1 Recombinant canine herpesviruses |
| 04/28/1999 | EP0910405A2 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection |
| 04/28/1999 | EP0910401A1 Compounds that inhibit the binding of raf-1 or 14-3-3 proteins to the beta chain of il-2 receptor, and pharmaceutical compositions containing same |
| 04/28/1999 | EP0910395A1 Pharmaceutical composition which is stable during storage and contains a thymus extract |
| 04/28/1999 | EP0910387A1 Apoptosis associated protein bbk |
| 04/28/1999 | EP0910384A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
| 04/28/1999 | EP0910361A1 Use of an osmolyte for treating the effects of an infection, an inflammation or an immune dysfunction |
| 04/28/1999 | EP0910358A1 Phenyl derivatives useful as blockers of chloride channels |
| 04/28/1999 | EP0784629B1 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteases |
| 04/28/1999 | EP0779888B1 Pyrimido [5,4-d]pyrimidines, drugs containing these compounds, their use, and process for preparing them |
| 04/28/1999 | EP0679092B1 Cytokine restraining agents |
| 04/28/1999 | EP0618907B1 1-(arylalkyl-aminoalkyl)imidazole derivatives, processes of preparation and use as therapeutical agents |
| 04/28/1999 | CN1215407A Human antibodies that bind huma TNF 'alpha' |
| 04/28/1999 | CN1215404A Non-dendritic backbone piptide carrier |
| 04/28/1999 | CN1215397A Acylated N-hydroxy methyl thalidomide prodrugs with immunomodulator action |
| 04/28/1999 | CN1215391A 6-phenylpyridyl-2-amine derivatives |
| 04/28/1999 | CN1215309A Implantable agarose-collagen beads containing cells which produce a diffusible biological product, and uses thereof |
| 04/27/1999 | US5898033 Antiinflammatory non-immunogenic conjugate comprising polyamino acid backbone having multiplicity of molecules of non-steroidal antiinflammatory agent linked thereto, which is preferentially internalized by antigen-processing cells |
| 04/27/1999 | US5897862 Immuno-stimulatory monoclonal antibodies |
| 04/27/1999 | CA2083826C Protein having cytokine type activity, recombinant dna coding for this protein, transformed cells and microorganisms |
| 04/27/1999 | CA2018085C Alpha-glycosyl hesperidin, and its preparation and uses |
| 04/24/1999 | CA2248170A1 A clone hwhhj20 |
| 04/23/1999 | CA2251342A1 Room temperature storable immunoglobulin preparation for intravenous injection |
| 04/22/1999 | WO1999019505A1 Process for the preparation of immunomodulatory polysaccharides from aloe |
| 04/22/1999 | WO1999019496A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | WO1999019484A1 T cell receptor-associated molecules (trams) and methods of use therefor |
| 04/22/1999 | WO1999019483A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | WO1999019480A2 Human receptor proteins; related reagents and methods |
| 04/22/1999 | WO1999019478A1 Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 04/22/1999 | WO1999019365A1 Novel pectic polysaccharides purified from angelica gigas nakai and purification method and use as immuno-stimulating agent thereof |
| 04/22/1999 | WO1999019349A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | WO1999019343A1 Viral clearance process |
| 04/22/1999 | WO1999019338A1 Inhibitors of nucleoside metabolism |
| 04/22/1999 | WO1999019322A1 ETHYL 4-(8-CHLORO-5, 6-DIHYDRO-11H- BENZO[5,6]CYCLOHEPTA [1,2-b]PYRIDIN -11-YLIDENE)-1- PIPERIDENE CARBOXYLATE POLYMORPH |
| 04/22/1999 | WO1999018997A1 Potentiator for antibody against lymphoid tumor |
| 04/22/1999 | WO1999018995A1 Immunogenic peptides from the hpv e7 protein |
| 04/22/1999 | WO1999018987A1 Ligand binding site of rage and uses thereof |
| 04/22/1999 | WO1999018961A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |
| 04/22/1999 | WO1999018801A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | WO1999018781A1 Dipeptide apoptosis inhibitors and the use thereof |
| 04/22/1999 | WO1999001556A3 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
| 04/22/1999 | WO1999001136A9 Novel substituted imidazole compounds |
| 04/22/1999 | CA2308118A1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 04/22/1999 | CA2306455A1 Human receptor proteins; related reagents and methods |
| 04/22/1999 | CA2306444A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 04/22/1999 | CA2306062A1 Methods and compositions for the treatment of autoimmune disease using heat shock proteins |
| 04/22/1999 | CA2305801A1 Ethyl 4-(8-chloro-5, 6-dihydro-11h- benzo[5,6]cyclohepta [1,2-b]pyridin -11-ylidene)-1- piperidene carboxylate polymorph |
| 04/22/1999 | CA2305698A1 Human progesterone receptor complex p23-like protein |
| 04/22/1999 | CA2304374A1 Method of preventing nephrotoxicity caused by cyclosporins and tacrolimus |